Get access

Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]-PK11195 PET

Authors

  • Anna L. Bartels MD,

    Corresponding author
    1. Department of Neurology, University Medical Centre Groningen (UMCG), University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
    • Department of Neurology, University Medical Centre Groningen (UMCG), University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
    Search for more papers by this author
  • Klaus L. Leenders MD, PhD

    1. Department of Neurology, University Medical Centre Groningen (UMCG), University of Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands
    Search for more papers by this author

Abstract

Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD) that contributes to ongoing neurodegeneration. PD brains and experimental PD models show elevated cytokine levels and up-regulation of inflammatory-associated factors as cyclo-oxygenase-2 and inducible nitric oxide oxidase. Antiinflammatory treatment reduced neuronal degeneration in experimental models. In this review, we summarize the place of neuroinflammation in the pathophysiology of PD. In vivo PET studies are discussed. These methods provide a means to monitor in vivo potential clinical relevance of antiinflammatory treatment strategies in PD. © 2007 Movement Disorder Society

Ancillary